Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Braun J, Baraliakos X, Hermann K-GA, et al. Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo-controlled GO-RAISE study. Ann Rheum Dis 2012;71:878–84. In table 3, the interquartile range for the median change at week 14 in the golimumab 50 mg group currently reads as 10.8, −0.3 and should be −10.8, −0.3.